These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Breast cancer and depot-medroxyprogesterone acetate: a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Lancet; 1991 Oct 05; 338(8771):833-8. PubMed ID: 1681212 [Abstract] [Full Text] [Related]
5. Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer; 1991 Sep 09; 49(2):186-90. PubMed ID: 1831802 [Abstract] [Full Text] [Related]
10. Depot-medroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Int J Cancer; 1991 Sep 09; 49(2):191-5. PubMed ID: 1831803 [Abstract] [Full Text] [Related]
12. Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer. Kaunitz AM. J Reprod Med; 1996 May 09; 41(5 Suppl):419-27. PubMed ID: 8725705 [Abstract] [Full Text] [Related]
13. Depot medroxyprogesterone acetate and breast cancer. A review of current knowledge. Chilvers CE. Drug Saf; 1996 Sep 09; 15(3):212-8. PubMed ID: 8879975 [Abstract] [Full Text] [Related]
14. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Thomas DB, Noonan L, Whitehead A. Bull World Health Organ; 1985 Sep 09; 63(3):513-9. PubMed ID: 2931206 [Abstract] [Full Text] [Related]
18. Depo medroxyprogesterone acetate (DMPA) and combined oral contraceptives and cervical carcinoma in-situ in women aged 50 years and under. Hoyo C, Cousins DS, Bisgrove EZ, Gaines MM, Schwingl PJ, Fortney JA. West Indian Med J; 2004 Dec 09; 53(6):406-12. PubMed ID: 15816269 [Abstract] [Full Text] [Related]